KIMBERLY-CLARK CORP (KMB)
Valor JustoFundamental
59
Precio
$97.43
Capitalización Bursátil
$32.27B
Parte 1 · Cuánto vale la empresa
Resumen
Kimberly-Clark makes disposable personal-care and tissue products — diapers (Huggies), feminine and adult care, paper towels and toilet paper (Kleenex, Scott) — sold mainly through supermarkets, mass retailers and pharmacies. Its North America business is the larger and more profitable half; a separate International Personal Care unit sells largely the same categories outside the US and Canada. It is also folding in Kenvue (Tylenol, Band-Aid, Listerine) through a pending acquisition, and moving its non-US tissue business into a joint venture with Brazil's Suzano.
Cómo genera ingresos
Kimberly-Clark sells everyday disposable products that customers repurchase every few weeks, so revenue depends on volume and price/mix rather than one-time big-ticket sales. It negotiates directly with a small number of very large retailers — Walmart alone is about 16% of net sales — who control shelf space and can push back hard on price increases, especially when store-brand alternatives sit right next to Kimberly-Clark's products. Profitability rises and falls largely with the cost of pulp, resin and other raw materials relative to what retailers accept in price increases.
Ingresos por segmento
Personal care and tissue brands sold in the US and Canada, Kimberly-Clark's largest and most profitable market.
Diapers, feminine and adult care products sold outside North America, largely in emerging markets.
Ventaja competitiva
Marca · EstrechaHuggies, Kleenex and Scott are recognized household names that let Kimberly-Clark charge more than unbranded alternatives and secure shelf space with retailers. But private-label products sit right next to them at lower prices in every category it competes in, and large retailers hold real bargaining power over listing and price, so the brand premium is real but limited rather than dominant.
Qué impulsa la demanda
DefensivoDiapers, tissue and paper towels are bought regardless of the economic cycle, since consumers rarely cut back on basic hygiene products even in a downturn, which keeps volumes fairly stable. The bigger swing factor is the input-cost cycle — pulp, resin and energy prices — and retailers' willingness to accept the price increases needed to offset it, not end-consumer demand itself.
Riesgos clave
- Retailer bargaining power — A handful of very large retailers, led by Walmart, control the shelf space Kimberly-Clark depends on and can resist price increases or favor private-label alternatives.
- Raw material cost volatility — Prices for pulp, resin, energy and other key inputs can rise sharply, and Kimberly-Clark may not be able to fully offset them through pricing without hurting volume.
- Kenvue acquisition integration — The pending Kenvue acquisition will substantially increase debt and carries execution risk; the deal could also be delayed, face regulatory obstacles, or fail to deliver the expected synergies.
- Private-label competition — Store-brand competitors, some with significantly lower development and manufacturing costs, offer comparable products at lower prices in nearly every category Kimberly-Clark serves.
Concentración de clientes
Los principales clientes representan el 16% de los ingresos
Walmart alone accounted for approximately 16% of net sales from continuing operations in 2025, concentrated mostly in the North America segment; losing shelf space or favorable terms with a retailer this size would be difficult to replace elsewhere.
Los argumentos a favor
Buyers argue that Kleenex, Huggies and Scott are habitual purchases that hold their shelf position through economic cycles, that adding Kenvue's health-care brands diversifies the business beyond paper and diaper categories, and that shedding the lower-margin international tissue business into the Suzano joint venture should lift overall margins.
Los argumentos en contra
Sellers worry that the Kenvue deal loads the balance sheet with new debt right as Kimberly-Clark still has to prove the acquisition's synergies, that a handful of retailers led by Walmart can squeeze pricing whenever input costs rise, and that private-label alternatives keep gaining share in categories where the brand premium is hardest to defend.
Written by the editors, published on 18 de agosto de 2026
Direct competitors
Who this company fights with for the same customers
Generated on 19 de septiembre de 2026 with claude-haiku-4-5 — shared with all users
P&G goes head to head with Kimberly-Clark on supermarket shelves worldwide in disposable diapers (Pampers vs Huggies), feminine care (Always vs Kotex) and paper towels and toilet tissue (Bounty and Charmin vs Scott and Cottonelle).
The Swedish hygiene group names Kimberly-Clark as a direct competitor in both personal care and tissue, and the two fight for the same customers in adult incontinence (TENA vs Depend) and in away-from-home washroom supplies sold to offices and hospitals (Tork vs Kimberly-Clark Professional).
Unicharm is the leading maker of baby diapers, feminine care and adult incontinence products across Japan, China and Southeast Asia, the same categories and the same fast-growing Asian consumers Kimberly-Clark targets with Huggies and Kotex.
Privately held by Koch Industries, Georgia-Pacific sells Angel Soft, Quilted Northern and Brawny in US supermarkets and Dixie and enMotion washroom systems to businesses, competing directly with Scott, Cottonelle and Kimberly-Clark Professional.
Ontex is one of the largest makers of private-label diapers, feminine pads and incontinence products for European and American retailers, the store-brand pressure Kimberly-Clark's 10-K singles out as a threat to its branded volumes.
Balance y Liquidez
Ingresos
$16.58B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$1.96B
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
$1.64B
Patrimonio Neto Total
$1.50B
Pasivo Total
$15.47B
Ratio de Liquidez
0.91
Cobertura de Intereses
9.18
Deuda/EBITDA
2.06
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$102.73
Precio Actual
$97.43
Margen de Seguridad
+5.2%
Rango de Valor Justo
$66.78 - $138.69
Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.
Métodos de Estimación
Métricas de Valoración
Ratio P/E
16.57
ROE
134.6%
Ratio P/B
18.52
P/FCF
17.80
Margen Bruto
36.8%
ROIC
18.6%
Radar de Rentabilidad
Creación de Valor (Ventaja Competitiva)
ROIC
18.6%
WACC
7.2%
ROIC − WACC
+11.4 pp
El ROIC supera el coste del capital: la empresa está creando valor para los accionistas.
Criterios de Análisis Fundamental
Superado (15)
- EPS shows upward trend
- ROIC 18.6%
- Gross Margin 36.8%
- P/FCF 17.80
- Operating Margin 14.3%
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 122.6%
- Earnings Surprise avg 2.9%
- Earnings Quality (OCF/NI) 1.70
- Share Dilution -1.2%
- Piotroski F-Score 5/9
Fallido (11)
- EPS CAGR 2.23%
- Price CAGR -1.54%
- P/B Ratio 18.52
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -3.0%
- Analyst Consensus 48% Buy
- Net Margin Trend 11.8% vs 14.8%
No disponible (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Señales mixtas: algunas áreas requieren atención
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Participaciones institucionales
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Michael D. Hsu | Chairman & CEO | 61 |
| Mr. Russell C. Torres | President & COO | 53 |
| Mr. Nelson Urdaneta | Senior VP, CFO & Interim Principal Accounting Officer, | 53 |
| Mr. Jeffrey P. Melucci J.D. | Chief Strategy, Business Development & Administrative Officer | 54 |
| Mr. Francesco Tinto | Chief Information & Global Business Services Officer | - |
| Mr. Christopher M. Jakubik C.F.A. | Investor Relations Contact | - |
| Ms. Suzana Blades | Senior VP & General Counsel | - |
| Ms. Preeti Binoy | Head Corporate Communications & Government Affairs - India | - |
| Ms. Stacey J. Valy Panayiotou | Chief Human Resources Officer | 52 |
| Mr. Ehab Abou-Oaf | Chief Executive Officer of Arbex | 58 |
Riesgo de Auditoría
3
Riesgo del Consejo
5
Riesgo de Compensación
6
Riesgo de Derechos del Accionista
4
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Documentos
- Ver documento
Informe anual (10-K)
Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.
Presentado el 2026-02-12
- Ver documento
Informe trimestral (10-Q)
Una actualización del desempeño financiero de los últimos tres meses.
Presentado el 2026-08-04
- Ver documento
Informe de hecho relevante (8-K)
Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.
Presentado el 2026-09-28
via SEC EDGAR
Historial de Resultados
via SEC EDGAR
Latest News
Recent headlines for KMB, sourced from Markets Gazette.